Dorman, Eric F. | Search NASA

DOE OSTI2021

Comparison of model predictions with measured proton-induced production of nickel and iridium isotopes

Calculations were performed to support method development for simultaneous production of Ni and Ir isotopes. Here, the work scope included development of the physical target, irradiation configuration, and post-irradiation radiochemical separations. The assumptions of predictive models previously developed were refined based upon the precise experimental configuration selected, including Os target material and a set of stacked targets for concurrent production of Ni and Ir isotopes. Model predictions of the reaction cross sections with EMPIRE 3.21 and implied isotopic yields are compared with proton beam irradiation measurements to refine model parameters and guide future experiments.

Isotope Production↗

DOE OSTI2020

A Solid-State Support for Separating Astatine-211 from Bismuth

Increasing access to the short-lived α-emitting radionuclide astatine-211 ( 211 At) has the potential to advance targeted α-therapeutic treatment of disease and to solve challenges facing the medical community. For example, there are numerous technical needs associated with advancing the use of 211 At in targeted α-therapy, e.g., improving 211 At chelates, developing more effective 211 At targeting, and characterizing in vivo 211 At behavior. There is an insufficient understanding of astatine chemistry to support these efforts. The chemistry of astatine is one of the least developed of all elements on the periodic table, owing to its limited supply and short half-life. Increasing access to 211 At could help address these issues and advance understanding of 211 At chemistry in general. Here, we contribute an extraction chromatographic processing method that simplifies 211 At production in terms of purification. It utilizes the commercially available Pre-Filter resin to rapidly (<1.5 h) isolate 211 At from irradiated bismuth targets (Bi decontamination factors ≥876 000), in reasonable yield (68–55%) and in a form that is compatible for subsequent in vivo study. We are excited about the potential of this procedure to address 211 At supply and processing/purification problems.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗